Invesco’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Invesco’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,358	Closed	-$310K	–	4012
2020 Q4	$310K	Buy	+2,358	New	+$208K	﹤0.01%	3406
2020 Q2	–	Sell	-97,446	Closed	-$4.77M	–	3719
2020 Q1	$4.77M	Buy	+97,446	New	+$4.96M	﹤0.01%	1914
2019 Q3	–	Sell	-46,273	Closed	-$1.44M	–	3741
2019 Q2	$1.44M	Buy	46,273 +1,383	+3%	+$37.5K	﹤0.01%	2868
2019 Q1	$1.05M	Buy	+44,890	New	+$720K	﹤0.01%	2991

Invesco's EIDX Position: Q1 2021 in Review

Invesco sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 2,358 shares — an estimated $310K sold.

Invesco first reported a position in EIDX in Q1 2019 and held it in 4 quarters. The position peaked at $4.77M in Q1 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Invesco reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Invesco sold 2,358 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $310K.
Invesco first reported a position in Eidos Therapeutics, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
Invesco's Eidos Therapeutics, Inc. Common Stock position peaked at $4.77M in Q1 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Invesco's 13F filing for Q1 2021, filed 17 May 2021.